Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Effect of hypoxia on angiogenesis related factors in glioblastoma cells.

Emara M, Allalunis-Turner J.

Oncol Rep. 2014 Apr;31(4):1947-53. doi: 10.3892/or.2014.3037. Epub 2014 Feb 20.

PMID:
24573635
2.

Hypoxia differentially upregulates the expression of embryonic, fetal and adult hemoglobin in human glioblastoma cells.

Emara M, Turner AR, Allalunis-Turner J.

Int J Oncol. 2014 Mar;44(3):950-8. doi: 10.3892/ijo.2013.2239. Epub 2013 Dec 31.

PMID:
24379112
3.

Adult, embryonic and fetal hemoglobin are expressed in human glioblastoma cells.

Emara M, Turner AR, Allalunis-Turner J.

Int J Oncol. 2014 Feb;44(2):514-20. doi: 10.3892/ijo.2013.2186. Epub 2013 Nov 22.

PMID:
24270851
4.

Notch signaling as a therapeutic target for breast cancer treatment?

Han J, Hendzel MJ, Allalunis-Turner J.

Breast Cancer Res. 2011 May 31;13(3):210. doi: 10.1186/bcr2875. Review.

5.

Knockdown of cytoglobin expression sensitizes human glioma cells to radiation and oxidative stress.

Fang J, Ma I, Allalunis-Turner J.

Radiat Res. 2011 Aug;176(2):198-207. Epub 2011 Jun 1.

PMID:
21631290
6.

Characterization and comparison of protein complexes initiated by the intracellular domain of individual Notch paralogs.

Han J, Allalunis-Turner J, Hendzel MJ.

Biochem Biophys Res Commun. 2011 Apr 15;407(3):479-85. doi: 10.1016/j.bbrc.2011.03.042. Epub 2011 Mar 23.

PMID:
21414294
7.

ADC response to radiation therapy correlates with induced changes in radiosensitivity.

Larocque MP, Syme A, Allalunis-Turner J, Fallone BG.

Med Phys. 2010 Jul;37(7):3855-61.

PMID:
20831093
8.

Hypoxic regulation of cytoglobin and neuroglobin expression in human normal and tumor tissues.

Emara M, Turner AR, Allalunis-Turner J.

Cancer Cell Int. 2010 Sep 9;10:33. doi: 10.1186/1475-2867-10-33.

9.

Monitoring T2 and ADC at 9.4 T following fractionated external beam radiation therapy in a mouse model.

Larocque MP, Syme A, Yahya A, Wachowicz K, Allalunis-Turner J, Fallone BG.

Phys Med Biol. 2010 Mar 7;55(5):1381-93. doi: 10.1088/0031-9155/55/5/008. Epub 2010 Feb 11.

PMID:
20150684
10.

Temporal and dose dependence of T2 and ADC at 9.4 T in a mouse model following single fraction radiation therapy.

Larocque MP, Syme A, Yahya A, Wachowicz K, Allalunis-Turner J, Fallone BG.

Med Phys. 2009 Jul;36(7):2948-54.

PMID:
19673193
11.

The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition.

Han J, Ma I, Hendzel MJ, Allalunis-Turner J.

Breast Cancer Res. 2009;11(4):R57. doi: 10.1186/bcr2347. Epub 2009 Aug 6.

12.

Expression and hypoxic up-regulation of neuroglobin in human glioblastoma cells.

Emara M, Salloum N, Allalunis-Turner J.

Mol Oncol. 2009 Feb;3(1):45-53. doi: 10.1016/j.molonc.2008.11.002. Epub 2008 Dec 12.

13.

Human polynucleotide kinase participates in repair of DNA double-strand breaks by nonhomologous end joining but not homologous recombination.

Karimi-Busheri F, Rasouli-Nia A, Allalunis-Turner J, Weinfeld M.

Cancer Res. 2007 Jul 15;67(14):6619-25.

14.

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta L, Bonnet S, Harry G, Hashimoto K, Porter CJ, Andrade MA, Thebaud B, Michelakis ED.

Cancer Cell. 2007 Jan;11(1):37-51.

15.
16.

mtDNA mutations in invasive cervix tumors: a retrospective analysis.

Allalunis-Turner J, Ma I, Hanson J, Pearcey RG.

Cancer Lett. 2006 Nov 18;243(2):193-201. Epub 2006 Jan 18.

PMID:
16412569
17.

Mutation in mitochondrial complex I ND6 subunit is associated with defective response to hypoxia in human glioma cells.

DeHaan C, Habibi-Nazhad B, Yan E, Salloum N, Parliament M, Allalunis-Turner J.

Mol Cancer. 2004 Jul 12;3:19.

18.

Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells.

Turcotte ML, Parliament M, Franko A, Allalunis-Turner J.

Br J Cancer. 2002 Feb 12;86(4):619-24.

19.

Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells.

Catania A, Urban S, Yan E, Hao C, Barron G, Allalunis-Turner J.

Neuro Oncol. 2001 Apr;3(2):89-98. doi: 10.1093/neuonc/3.2.89.

20.

cDNA expression array analysis of DNA repair genes in human glioma cells that lack or express DNA-PK.

Galloway AM, Allalunis-Turner J.

Radiat Res. 2000 Dec;154(6):609-15.

PMID:
11096417
21.

Protein-DNA complexes containing DNA-dependent protein kinase in crude extracts from human and rodent cells.

Ting NS, Chan DW, Lintott LG, Allalunis-Turner J, Lees-Miller SP.

Radiat Res. 1999 Apr;151(4):414-22.

PMID:
10190493
22.

Lack of correlation between ATM protein expression and tumour cell radiosensitivity.

Chan DW, Gately DP, Urban S, Galloway AM, Lees-Miller SP, Yen T, Allalunis-Turner J.

Int J Radiat Biol. 1998 Aug;74(2):217-24.

PMID:
9712550
23.

Use of a postlabelling assay to examine the removal of radiation-induced DNA lesions by purified enzymes and human cell extracts.

Weinfeld M, Lee J, Ruiqi G, Karimi-Busheri F, Chen D, Allalunis-Turner J.

Mutat Res. 1997 Aug 1;378(1-2):127-37.

PMID:
9288891
24.

Intact G2-phase checkpoint in cells of a human cell line lacking DNA-dependent protein kinase activity.

Allalunis-Turner J, Barron GM, Day RS 3rd.

Radiat Res. 1997 Mar;147(3):284-7.

PMID:
9052673
25.

The DNA damage response in DNA-dependent protein kinase-deficient SCID mouse cells: replication protein A hyperphosphorylation and p53 induction.

Fried LM, Koumenis C, Peterson SR, Green SL, van Zijl P, Allalunis-Turner J, Chen DJ, Fishel R, Giaccia AJ, Brown JM, Kirchgessner CU.

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13825-30.

26.

Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line.

Lees-Miller SP, Godbout R, Chan DW, Weinfeld M, Day RS 3rd, Barron GM, Allalunis-Turner J.

Science. 1995 Feb 24;267(5201):1183-5.

PMID:
7855602
27.

Is tumor cell radiation resistance correlated with metastatic ability?

Suit H, Allam A, Allalunis-Turner J, Brock W, Girinsky T, Hill S, Hunter N, Milas L, Pearcey R, Peters L, et al.

Cancer Res. 1994 Apr 1;54(7):1736-41.

28.

Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.

Taghian A, Ramsay J, Allalunis-Turner J, Budach W, Gioioso D, Pardo F, Okunieff P, Bleehen N, Urtasun R, Suit H.

Int J Radiat Oncol Biol Phys. 1993 Jan 15;25(2):243-9.

PMID:
8380568
29.

Animal tumor models for the evaluation of in-vivo diagnostic radiotracers.

Wiebe LI, Allalunis-Turner J, Franko A, Kanclerz A.

Am J Physiol Imaging. 1991 Jul-Sep;6(3):133-49. Review. No abstract available.

PMID:
1772695
30.

The sensitivities of SV40-transformed human fibroblasts to monofunctional and DNA-crosslinking alkylating agents.

Miyakoshi J, Scudiero DA, Allalunis-Turner J, Day RS 3rd.

Mutat Res. 1991 Jan;254(1):55-64.

PMID:
1846027
31.

Evaluation of cell subpopulations isolated from human tumor xenografts by centrifugal elutriation.

Keng PC, Allalunis-Turner J, Siemann DW.

Int J Radiat Oncol Biol Phys. 1990 May;18(5):1061-7.

PMID:
2347715
32.

Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons.

Miyakoshi J, Dobler KD, Allalunis-Turner J, McKean JD, Petruk K, Allen PB, Aronyk KN, Weir B, Huyser-Wierenga D, Fulton D, et al.

Cancer Res. 1990 Jan 15;50(2):278-83.

PMID:
2295067
33.

Bone marrow toxicity of total-body irradiation combined with radiosensitizers.

Shields AF, Applebaum FR, Graham T, Deeg HJ, Allalunis-Turner J, Chapman JD, Storb R.

Radiat Res. 1989 Nov;120(2):364-9.

PMID:
2533359
34.

The in vitro sensitivities to radiation and misonidazole of mouse bone marrow cells derived from different microenvironments.

Allalunis-Turner J, Chapman JD.

Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Mar;49(3):415-22.

PMID:
3485590

Supplemental Content

Loading ...
Support Center